Office-Based Asthma Screening Intervention

This study has been completed.
Sponsor:
Collaborators:
Halcyon Hill Foundation
Robert Wood Johnson Foundation
Information provided by:
University of Rochester
ClinicalTrials.gov Identifier:
NCT00156468
First received: September 8, 2005
Last updated: May 11, 2011
Last verified: May 2011
  Purpose

In prior work, we found that even children who have been seen by their physicians within the prior six months were frequently misclassified as having mild rather than persistent asthma. This study evaluations whether systematic office-based screening assists primary care physicians in identifying children with significant asthma and improves preventive care for asthma. We hypothesize that standardized screening in the office setting will improve the physician's ability to (a) identify children with significant asthma and (b) prescribe appropriate preventive medications.


Condition Intervention
Asthma
Behavioral: Provider Prompt

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Prevention
Official Title: Office-Based Asthma Screening Intervention

Resource links provided by NLM:


Further study details as provided by University of Rochester:

Primary Outcome Measures:
  • "Preventive Medication Actions (PMA)" taken by the provider at the time of the child's visit. A "PMA" is defined as a new medication prescription or change in medication dose.

Secondary Outcome Measures:
  • Alternate actions taken by the provider such as: discussion of environmental controls, medication refills, etc.

Estimated Enrollment: 365
Study Start Date: October 2003
Estimated Study Completion Date: September 2005
  Eligibility

Ages Eligible for Study:   2 Years to 12 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Children ages 2-12
  • Children arriving for an office visit in two Rochester, NY pediatric clinics
  • Children with a prior diagnosis of asthma AND an exacerbation of symptoms within the previous 2 years

Exclusion Criteria:

  • Children arriving at the office visit with an adult that is not their parent or guardian
  • Children arriving at the office visit with a parent or guardian that does not speak English
  • Children with other medical conditions making the assessment of asthma severity difficult (cystic fibrosis, heart conditions, etc.)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00156468

Locations
United States, New York
University of Rochester
Rochester, New York, United States, 14642
Sponsors and Collaborators
University of Rochester
Halcyon Hill Foundation
Robert Wood Johnson Foundation
Investigators
Principal Investigator: Jill S Halterman, MD, MPH University of Rochester
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00156468     History of Changes
Other Study ID Numbers: 10035
Study First Received: September 8, 2005
Last Updated: May 11, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on October 21, 2014